SEC Form 4 research
| Issuer | Acrivon Therapeutics, Inc. |
|---|---|
| Tickers | ACRV |
| Reporting owners | 31 |
| Officers and directors | 8 |
| Last public filing | 2026-10-07 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-05 | Miller Mary | S | 294 | $1.99 | Not reported |
| 2026-09-02 | 2026-08-31 | Levin Michaela | A | 30,000 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Levin Michaela | A | 130,000 | $0 | Not reported |
| 2026-08-27 | 2026-08-25 | Blume-Jensen Peter, Masson Kristina | S | 14,036 | $2.21 | Not reported |
| 2026-08-20 | 2026-08-18 | Peterson Katharine | S | 101 | $2.01 | Not reported |
| 2026-08-20 | 2026-08-18 | Miller Mary | S | 185 | $2.01 | Not reported |
| 2026-08-20 | 2026-08-18 | Gamelin Erick | S | 400 | $2.01 | Not reported |
| 2026-08-20 | 2026-08-18 | Devroe Eric | S | 604 | $2.01 | Not reported |
| 2026-08-20 | 2026-08-18 | Blume-Jensen Peter, Masson Kristina | S | 484 | $2.01 | Not reported |
| 2026-08-20 | 2026-08-18 | Blume-Jensen Peter, Masson Kristina | S | 1,229 | $2.01 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.